IP Library › Granted Patent US 7,786,321
Granted Patent B2
US 7,786,321 · App. 12/222,147 · Granted Aug 31, 2010

Compounds of the N-acylamino amide family compositions comprising them and uses thereof

Assignee: L'Oreal S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,786,321
App. No.
12/222,147
Granted
Aug 31, 2010
Kind
B2
Abstract

The invention concerns novel compounds of the N-acylamino-amide family, compositions, in particular cosmetic or pharmaceutical, containing them, and their use for treating body or face skin ageing, whether chronobiologic or light-induced, and in particular skin ageing caused by decrease of skin elasticity and/or by collagen degradation in the structure for tissues.

Claims (20)

1. A compound chosen from compounds of formula (I):

wherein:

Y is O,

R 1 is H, methyl, ethyl, propyl, or isopropyl,

R 2 is a linear, or branched C 1-18 alkyl,

R 3 is a radical chosen from those of formulae (II) and (III):

(II) -A-C 6 H (5-y) —B y wherein y is 0 and A is —CH 2 , —CH 2 CH 2 , or —CH 2 CH 2 CH 2 , and

(III) —C 6 H (5-y′) —B y′ wherein y′ is 0 or 1, and B is a perfluorinated hydrocarbon-based radical chosen from a methyl, theyl, propyl or isopropyl radical,

X is —OH or —OR 4 wherein R 4 is a linear, branched, or cyclic C 1-6 alkyl,

the mineral acid and organic acid salts thereof, and the optical isomers thereof, in isolated form and as a racemic mixture.

2. The compound according to claim 1 , wherein B is —CF 3 .

3. The compound according to claim 1 , wherein R 1 is methyl.

4. The compound according to claim 1 , wherein R 2 is methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl or isobutyl.

5. The compound according to claim 4 , wherein R 2 is isopropyl.

6. The compound according to claim 1 , wherein X is —OH, —OCH 3 , —OC 2 H 5 , —OC 3 H 7 , or —OC 4 H 9 .

7. The compound according to claim 1 , wherein the compound is chosen from:

{2-[acetyl(3-trifluoromethylphenyl)amino]-3-methylbutyrylamino}acetic acid,

ethyl {2-[acetyl(3-trifluoromethylphenyl)amino]-3-methylbutyrylamino}acetate,

[2-(acetylbenzylamino)-3-methylbutyrylamino]acetic acid, and

ethyl[2-(acetylbenzylamino)-3-methylbutyrylamino]acetate.

Priority Claims (1)
FR 00 07344 · Jun 8, 2000 · national
Continuity (3)
Continuation 1110281200 · Apr 11, 2005
Division 1029744200 · Dec 6, 2002
Related Publication 20080293962A1 · Nov 27, 2008